Gabapentin as a drug with a broad potential. Presentation of its use in medical conditions beyond the official registration
DOI:
https://doi.org/10.12775/JEHS.2022.12.11.017Keywords
gabapentyna, alcohol withdrawal, itching; menopause, anxiety disorders, abuseAbstract
Introduction: Gabapentin is a drug used for monotherapy or adjunctive therapy of simple and complex partial epileptic seizures in adults and children. It is also used to treat neuropathic pain for adults. There are reports in the medical literature of the effective use of gabapentin in the treatment of other conditions. Let's take a closer look at its therapeutic potential.
Aim of the study: The overview of current literature knowledge about the usage of gabapentin in various medical conditions within the fields of toxicology, dermatology, gynecology, psychiatry branches' issues, with indicating the potential abuse.
Materials and Methods: We reviewed the literature available in the PubMed database, using the keywords.
Results: Gabapentin is an anticonvulsant drug structurally similar to gamma-aminobutyric acid (GABA). It is considered to be a centrally acting analog of GABA, nevertheless, it presents a different molecular mechanism comparing to the other drugs that affect GABA-ergic transmission. The registered indications for its use are the treatment of seizures within adults and children and neuropathic pain in adults. The literature reveals that gabapentin is also used in the treatment of alcohol abuse disorders within the patients with alcohol withdrawal symptoms, the treatment of pruritus, hot flashes during menopause and the treatment of anxiety disorder.
Summary: Due to the ambiguous effects of gabapentin usage, it can be applied to treat various medical conditions. Nevertheless, the usage of this drug described in the literature requires additional studies on a larger group of patients to confirm the findings.
References
Anton RF, Latham P, Voronin K, et al. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial. JAMA Intern Med. 2020 May 1;180(5):728-736. doi: 10.1001/jamainternmed.2020.0249. PMID: 32150232; PMCID: PMC7063541.
Buttram ME, Kurtz SP, Dart RC, et al. Law enforcement-derived data on gabapentin diversion and misuse, 2002-2015: diversion rates and qualitative research findings. Pharmacoepidemiol Drug Saf. 2017 Sep;26(9):1083-1086. doi: 10.1002/pds.4230. Epub 2017 May 10. PMID: 28493425.
Berlin RK, Butler PM, Perloff MD. Gabapentin Therapy in Psychiatric Disorders: A Systematic Review. Prim Care Companion CNS Disord. 2015 Oct 22;17(5):10.4088/PCC.15r01821. doi: 10.4088/PCC.15r01821. PMID: 26835178; PMCID: PMC4732322.
Mason BJ, Quello S, Shadan F. Gabapentin for the treatment of alcohol use disorder. Expert Opin Investig Drugs. 2018 Jan;27(1):113-124. doi: 10.1080/13543784.2018.1417383. Epub 2017 Dec 23. PMID: 29241365; PMCID: PMC5957503.
Anton RF, Myrick H, Wright TM, et al. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011 Jul;168(7):709-17. doi: 10.1176/appi.ajp.2011.10101436. Epub 2011 Mar 31. PMID: 21454917; PMCID: PMC3204582.
Patel P, Patel K, Pandher K, et al. The Role of Psychiatric, Analgesic, and Antiepileptic Medications in Chronic Pruritus. Cureus. 2021 Aug 17;13(8):e17260. doi: 10.7759/cureus.17260. PMID: 34522555; PMCID: PMC8425105.
Mittal A, Agarwal C, Balai M, et al. Gabapentin and pregabalin in dermatology. Indian J Dermatol Venereol Leprol. 2018 Sep-Oct;84(5):634-640. doi: 10.4103/ijdvl.IJDVL_480_17. PMID: 29855453.
Gunal AI, Ozalp G, Yoldas TK, et al. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant. 2004 Dec;19(12):3137-9. doi: 10.1093/ndt/gfh496. PMID: 15575002.
Naini AE, Harandi AA, Khanbabapour S, et al. Gabapentin: a promising drug for the treatment of uremic pruritus. Saudi J Kidney Dis Transpl. 2007 Sep;18(3):378-81. PMID: 17679749.
Yilmaz S, Ceyhan AM, Baysal Akkaya V. Świąd ramienno-promieniowy skutecznie leczony gabapentyną. J Dermatol 2010;37:662-5.
Mendham JE. Gabapentyna w leczeniu swędzenia wywołanego oparzeniami i gojeniem się ran u dzieci: badanie pilotażowe. Oparzenia 2004;30:851-3.
Kaul I, Amin A, Rosenberg M, et al.. Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review. Burns. 2018 Mar;44(2):414-422. doi: 10.1016/j.burns.2017.07.018. Epub 2017 Aug 16. PMID: 28822592.
Ahuja RB, Gupta R, Gupta G, et al.. A comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus. Burns. 2011 Mar;37(2):203-7. doi: 10.1016/j.burns.2010.06.004. Epub 2010 Nov 13. PMID: 21075537.
Yoon SH, Lee JY, Lee C, et al. Gabapentin for the treatment of hot flushes in menopause: a meta-analysis. Menopause. 2020 Apr;27(4):485-493. doi: 10.1097/GME.0000000000001491. PMID: 32049930.
Toulis KA, Tzellos T, Kouvelas D, et al. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis. Clin Ther. 2009 Feb;31(2):221-35. doi: 10.1016/j.clinthera.2009.02.006. PMID: 19302896.
Houghton KT, Forrest A, Awad A, et al. Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis. BMJ Open. 2017 Mar 27;7(3):e013433. doi: 10.1136/bmjopen-2016-013433. PMID: 28348186; PMCID: PMC5372050.
Greenblatt HK, Greenblatt DJ. Gabapentin and Pregabalin for the Treatment of Anxiety Disorders. Clin Pharmacol Drug Dev. 2018 Mar;7(3):228-232. doi: 10.1002/cpdd.446. PMID: 29579375.
Hong JSW, Atkinson LZ, Al-Juffali N, et al. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Mol Psychiatry. 2022 Mar;27(3):1339-1349. doi: 10.1038/s41380-021-01386-6. Epub 2021 Nov 24. PMID: 34819636; PMCID: PMC9095464.
Rouse S, Wodziak M. Intractable Hiccups. Curr Neurol Neurosci Rep. 2018 Jun 22;18(8):51. doi: 10.1007/s11910-018-0856-0. PMID: 29934880.
Guttuso T Jr. Gabapentin's anti-nausea and anti-emetic effects: a review. Exp Brain Res. 2014 Aug;232(8):2535-9. doi: 10.1007/s00221-014-3905-1. Epub 2014 Mar 26. PMID: 24668130.
Guttuso T Jr, Messing S, Tu X, et al. Effect of gabapentin on hyperemesis gravidarum: a double-blind, randomized controlled trial. Am J Obstet Gynecol MFM. 2021 Jan;3(1):100273. doi: 10.1016/j.ajogmf.2020.100273. Epub 2020 Oct 29. PMID: 33451591.
Chaurasia A, Ishrat S, Tiwari R. Gabapentin for cessation of smoking and non-smoking tobacco habits in Indian population. Minerva Dent Oral Sci. 2021 Jun;70(3):103-111. doi: 10.23736/S2724-6329.20.04410-6. Epub 2020 Oct 23. PMID: 33094931.
Smith RV, Havens JR, Walsh SL. Gabapentin misuse, abuse and diversion: a systematic review. Addiction. 2016 Jul;111(7):1160-74. doi: 10.1111/add.13324. Epub 2016 Mar 18. PMID: 27265421; PMCID: PMC5573873.
Bonnet U, Scherbaum N. How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol. 2017 Dec;27(12):1185-1215. doi: 10.1016/j.euroneuro.2017.08.430. Epub 2017 Oct 5. PMID: 28988943.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Aleksandra Paulina Banasiak, Jakub Rafał Pierzchała, Katarzyna Bednarz, Jakub Kasprowicz, Patryk Banaś, Natalia Sobańska, Rafał Teichman, Justyna Adamus, Kamila Abram, Michał Hyjek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 646
Number of citations: 0